{"Name":"Versartis","perma":"versartis","BasicInfo":{"funded":"2008-12-01","isClosed":false,"closed":null,"short":"Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders."},"FundingRounds":[{"funding_type":"venture","series":"e","announcedDate":"2014-02-19","moneyRaised":55000000},{"funding_type":"venture","series":"d","announcedDate":"2013-10-08","moneyRaised":20000000},{"funding_type":"venture","series":"c","announcedDate":"2013-07-22","moneyRaised":12499999},{"funding_type":"venture","series":"c","announcedDate":"2013-01-15","moneyRaised":25000000},{"funding_type":"venture","series":"b","announcedDate":"2011-02-16","moneyRaised":21000000},{"funding_type":"venture","series":"a","announcedDate":"2009-06-02","moneyRaised":11000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"VSAR","shares":6000000,"date":"2014-03-24","openPrice":21,"moneyRaised":126000000,"valuation":489000000},"Investments":[],"Products":[],"CurrentTeam":[{"title":"SVP, Business Development","started":null,"ended":null,"firstName":"Paul","lastName":"Westberg"},{"title":"Co-Founder & CEO","started":null,"ended":null,"firstName":"Jeffrey","lastName":"Clearland"},{"title":"Vice President, Regulatory Affairs","started":null,"ended":null,"firstName":"Karl","lastName":"Trass"},{"title":"Vice President, Product Development","started":null,"ended":null,"firstName":"Rajendra","lastName":"Mohabir"},{"title":"Vice President, Clinical Operations","started":null,"ended":null,"firstName":"Eric","lastName":"Humphriss"},{"title":"Chief Financial Officer","started":null,"ended":null,"firstName":"Joshua","lastName":"Brumm"},{"title":"Senior Vice President, Medical Affairs","started":null,"ended":null,"firstName":"Bert","lastName":"Bakker"},{"title":"Vice President, Clinical Development","started":null,"ended":null,"firstName":"George","lastName":"Bright"}],"PastTeam":[]}
